These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23389285)

  • 1. Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?
    Ishida H; Kumamoto K; Ishibashi K; Hatano S; Matsuzawa T; Okada N; Kumagai Y; Baba H; Haga N
    Tech Coloproctol; 2013 Dec; 17(6):647-52. PubMed ID: 23389285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
    Zani S; Papalezova K; Stinnett S; Tyler D; Hsu D; Blazer DG
    J Surg Oncol; 2013 Mar; 107(4):307-11. PubMed ID: 22811275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.
    Al-Batran SE; Homann N; Pauligk C; Illerhaus G; Martens UM; Stoehlmacher J; Schmalenberg H; Luley KB; Prasnikar N; Egger M; Probst S; Messmann H; Moehler M; Fischbach W; Hartmann JT; Mayer F; Höffkes HG; Koenigsmann M; Arnold D; Kraus TW; Grimm K; Berkhoff S; Post S; Jäger E; Bechstein W; Ronellenfitsch U; Mönig S; Hofheinz RD
    JAMA Oncol; 2017 Sep; 3(9):1237-1244. PubMed ID: 28448662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection.
    Nitzkorski JR; Farma JM; Watson JC; Siripurapu V; Zhu F; Matteotti RS; Sigurdson ER
    Ann Surg Oncol; 2012 Feb; 19(2):379-83. PubMed ID: 21861213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.
    Pelz JO; Chua TC; Esquivel J; Stojadinovic A; Doerfer J; Morris DL; Maeder U; Germer CT; Kerscher AG
    BMC Cancer; 2010 Dec; 10():689. PubMed ID: 21176206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer.
    Thomay AA; Nagorney DM; Cohen SJ; Sigurdson ER; Truty MJ; Burtness B; Hall MJ; Chun YS
    J Gastrointest Surg; 2014 Jan; 18(1):69-74. PubMed ID: 24002765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer.
    Hompes D; Aalbers A; Boot H; van Velthuysen ML; Vogel W; Prevoo W; van Tinteren H; Verwaal V
    Colorectal Dis; 2014 Aug; 16(8):O264-72. PubMed ID: 24433532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.
    Hompes D; Boot H; van Tinteren H; Verwaal V
    J Surg Oncol; 2011 Sep; 104(3):269-73. PubMed ID: 21465492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer.
    Tsutsumi S; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Asao T; Kuwano H
    Hepatogastroenterology; 2014 May; 61(131):633-7. PubMed ID: 26176048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
    Shitara K; Yuki S; Yamazaki K; Naito Y; Fukushima H; Komatsu Y; Yasui H; Takano T; Muro K
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):595-603. PubMed ID: 23250506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change.
    Bhandare M; Patil P; Pai V; Bhamre R; Engineer R; Ostwal V; Saklani A
    Clin Colorectal Cancer; 2017 Jun; 16(2):e1-e6. PubMed ID: 27670895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
    Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
    Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical use of capecitabine plus oxaliplatin (CAPEOX) with bevacizumab for patients with metastatic colorectal cancer that cannot expect conversion therapy.
    Yokomizo H; Yoshimatsu K; Otani T; Osawa G; Nakayama M; Matsumoto A; Yano Y; Okayama S; Naritaka Y
    Hepatogastroenterology; 2013; 60(128):1911-5. PubMed ID: 24719926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
    Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
    Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin.
    Eveno C; Passot G; Goéré D; Soyer P; Gayat E; Glehen O; Elias D; Pocard M
    Ann Surg Oncol; 2014 Jun; 21(6):1792-800. PubMed ID: 24337648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
    Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern-day palliative chemotherapy for metastatic colorectal cancer: does colonic resection affect survival?
    Lau JWL; Chang HSY; Lee KY; Gwee YX; Lee WQ; Chong CS
    ANZ J Surg; 2018 Nov; 88(11):E772-E777. PubMed ID: 29938886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative complications after neoadjuvant chemotherapy with and without bevacizumab for colorectal liver metastases.
    Lubezky N; Winograd E; Papoulas M; Lahat G; Shacham-Shmueli E; Geva R; Nakache R; Klausner J; Ben-Haim M
    J Gastrointest Surg; 2013 Mar; 17(3):527-32. PubMed ID: 23299220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
    Wong R; Cunningham D; Barbachano Y; Saffery C; Valle J; Hickish T; Mudan S; Brown G; Khan A; Wotherspoon A; Strimpakos AS; Thomas J; Compton S; Chua YJ; Chau I
    Ann Oncol; 2011 Sep; 22(9):2042-2048. PubMed ID: 21285134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.